Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | MITF | O75030 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | PKM | P14618 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | CCR6 | P51684 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.38 |
| ▸ | GAA | P10253 | 3/20 | 0.38 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.38 |
| ▸ | CES1 | P23141 | 1/20 | 0.38 |
| ▸ | ALPL | P05186 | 1/20 | 0.38 |
| ▸ | PARP1 | P09874 | 1/20 | 0.38 |
| ▸ | PRKD3 | O94806 | 2/20 | 0.36 |
| ▸ | PRKCG | P05129 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL929420 | 0.98 | ALDH1A1 (0.40) | ALDH1A1MAPK1NPSR1MAPTMEN1 | |
| SCHEMBL2544260 | 0.85 | PTPN1 (0.53) | ALDH1A1MAPK1NPSR1MAPTKDM4E | |
| SCHEMBL5414511 | 0.83 | MAOA (0.39) | ALDH1A1MAPK1MAPTMEN1KMT2A | |
| SCHEMBL1050913 | 0.82 | GSK3B (0.41) | NPSR1MAPTMEN1CYP1A2CYP2C9 | |
| SCHEMBL28050899 | 0.82 | KMT2A (0.44) | ALDH1A1MAPTMEN1CYP2C9PKM | |
| SCHEMBL10714445 | 0.79 | PTPN1 (0.50) | ALDH1A1MAPK1NPSR1MAPTCYP1A2 | |
| SCHEMBL121405 | 0.78 | GSK3B (0.50) | ALDH1A1MAPK1NPSR1MAPTMEN1 | |
| SCHEMBL27664385 | 0.78 | GSK3B (0.50) | ALDH1A1MAPK1NPSR1MAPTMEN1 | |
| SCHEMBL11120799 | 0.77 | GSK3B (0.48) | ALDH1A1MAPK1NPSR1MAPTMEN1 | |
| SCHEMBL8413957 | 0.75 | MEN1 (0.44) | ALDH1A1MAPK1NPSR1MAPTMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025090402-A1 | DEBONDABLE ADHESIVE | Geisys Ventures, LLC (US) | 2025-05-01 | — | — | WO | claimed |
| CN-119569911-A | Gamma-cyclodextrin polyrotaxane with macromolecule shaft and chain end grafted second-generation dendritic polylysine and preparation method thereof | 南京大学 | 2025-03-07 | — | — | CN | claimed |
| CN-111303657-A | Microcapsule type dye and preparation method and application method thereof | TCL华星光电技术有限公司 | 2020-06-19 | — | — | CN | claimed |
| US-20180044495-A1 | REVERSIBLY CROSS-LINKABLE RESIN | OWENS CORNING INTELLECTUAL CAPITAL, LLC | 2018-02-15 | — | — | US | claimed |
| CN-121895257-A | High-stability single-donor binary crosslinked organic photoelectric material, and preparation method and application thereof | 广州大学 | 2026-04-21 | — | — | CN | disclosed |
| US-12503455-B2 | Nucleic acid-binding photoprobes and uses thereof | ARRAKIS THERAPEUTICS, INC. (US) | 2025-12-23 | — | — | US | disclosed |
| US-20250223396-A1 | GLYCIDYL ETHER GROUP-CONTAINING COMPOUND, CURABLE RESIN COMPOSITION, CURED PRODUCT, AND LAMINATE | DIC CORPORATION (JP) | 2025-07-10 | — | — | US | disclosed |
| US-20250179237-A1 | GLYCIDYL ETHER GROUP-CONTAINING COMPOUND, CURABLE RESIN COMPOSITION, CURED PRODUCT, AND LAMINATE | DIC CORPORATION (JP) | 2025-06-05 | — | — | US | disclosed |
| WO-2025090402-A1 | DEBONDABLE ADHESIVE | Geisys Ventures, LLC (US) | 2025-05-01 | — | — | WO | disclosed |
| EP-4527869-A1 | GLYCIDYL ETHER GROUP-CONTAINING COMPOUND, CURABLE RESIN COMPOSITION, CURED PRODUCT, AND LAMINATE | DIC Corporation (JP) | 2025-03-26 | — | — | EP | disclosed |
| EP-4527870-A1 | GLYCIDYL ETHER GROUP-CONTAINING COMPOUND, CURABLE RESIN COMPOSITION, CURED PRODUCT, AND LAMINATE | DIC Corporation (JP) | 2025-03-26 | — | — | EP | disclosed |
| WO-2025049634-A1 | GLYCAN CONJUGATE COMPOSITIONS AND METHODS | GANNA BIO, INC. (US) | 2025-03-06 | — | — | WO | disclosed |
| US-20100099798-A1 | REVERSIBLE VISCOSITY REDUCING POLYMER | UNITED STATES OF AMERICA, THE, AS REPRESENTED BY THE ARMY SECRETARY OF THE | 2010-04-22 | — | — | US | disclosed |
| CN-101489927-A | Complexes of carbon nanotubes and fullerences with molecular-clips and use thereof | IBM (US) | 2009-07-22 | — | — | CN | disclosed |
| EP-2076463-A2 | COMPLEXES OF CARBON NANOTUBES AND FULLERENCES WITH MOLECULAR-CLIPS AND USE THEREOF | International Business Machines Corporation (US) | 2009-07-08 | — | — | EP | disclosed |
| WO-2008048732-A2 | COMPLEXES OF CARBON NANOTUBES AND FULLERENES WITH MOLECULAR-CLIPS AND USE THEREOF | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2008-04-24 | — | — | WO | disclosed |
| WO-2008011623-A2 | COMPLEXES OF CARBON NANOTUBES AND FULLERENES WITH MOLECULAR-CLIPS AND USE THEREOF | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2008-01-24 | — | — | WO | disclosed |
| US-20070196592-A1 | Stretched Film, Process For The Production Thereof And Laminated Material | TEIJIN DUPONT FILMS JAPAN LIMITED | 2007-08-23 | — | — | US | disclosed |
| EP-1743915-A1 | ORIENTED FILM, PROCESS FOR PRODUCING THE SAME AND LAMINATE THEREOF | Teijin Dupont Films Japan Limited (JP) | 2007-01-17 | — | — | EP | disclosed |
| US-5965746-A | REACTING AN AMINO GROUP-CONTAINING N-CYCLIC COMPOUND WITH MALEIC ANHYDRIDE IN ACETIC ACID TO OBTAIN AN N-CYCLIC MALEAMIC ACID, ADDING HEXAMETHYLDISILAZANE, CYCLIZING TO FORM N-CYCLIC MALEIMIDE, USE AS A FLUORESCENT DYES | AISIN SEIKI KABUSHIKI KAISHA (JP) | 1999-10-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12503455-B2 | Nucleic acid-binding photoprobes and uses thereof | NSUN3, NSUN2, TARBP1 | ALDH1A1 891/4885MAPK1 4771/4885NPSR1 1128/4885 |
| US-20180044495-A1 | REVERSIBLY CROSS-LINKABLE RESIN | FRG1, MTCL3, FGB | ALDH1A1 3481/4885MAPK1 4500/4885NPSR1 2794/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.